Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214070 · ClinicalTrials.gov registry record · Phase 4
Functional Vision in TBI
A Phase 4 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT01214070: Clinical Trial Phase 4 study, sponsored by VA Office of Research and Development.
NCT01214070 is a Phase 4 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 110 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01214070, a Phase 4 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
The objective of this study is to test functional vision outcome measures that reflect the loss in everyday life tasks that require vision and that are sensitive to changes after a course of vision rehabilitation in Veterans/participants with TBI.
Interventions
- BEHAVIORAL Sham
- OTHER Vision Restoration Therapy
- BEHAVIORAL NVT Eye Scanning Therapy
- BEHAVIORAL Eccentric Viewing Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-06-01 |
| Est. Completion | 2013-11-21 |
| Phase | Phase 4 |
Why NCT01214070 stopped before completion
NCT01214070 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 4 interventions - of which Sham is the first listed.
NCT01214070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01214070 about?
NCT01214070 is a clinical study titled "Functional Vision in TBI". The objective of this study is to test functional vision outcome measures that reflect the loss in everyday life tasks that require vision and that are sensitive to changes after a course of vision rehabilitation in Veterans/participants with TBI.
What is the current status of trial NCT01214070?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2012-06-01. Estimated completion is 2013-11-21.
What interventions are being tested in trial NCT01214070?
The interventions under investigation include: Sham (BEHAVIORAL), Vision Restoration Therapy (OTHER), NVT Eye Scanning Therapy (BEHAVIORAL), Eccentric Viewing Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01214070?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01214070's enrollment target sits among peer trials
110 727th of 2000 higher than 1,264 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI